Anlon Healthcare (NSE:AHCL) Notes Receivable: ₹0 Mil (As of Mar. 2026)


NSE:AHCL Anlon Healthcare Ltd NSE:AHCL
17 GF Score
Price ₹15.90
! 5 Warning Signs
View Full Analysis

What is Anlon Healthcare Notes Receivable?

Anlon Healthcare NSE:AHCL 17 Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:AHCL with a GF Score™ of 17/100. The stock has 5 warning signs investors should review.

Anlon Healthcare's Notes Receivable for the quarter that ended in Mar. 2026 was ₹0 Mil.

Anlon Healthcare Notes Receivable Related Terms

Anlon Healthcare Notes Receivable Historical Data

* Premium members only.

The historical data trend for Anlon Healthcare's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anlon Healthcare Notes Receivable Chart

Anlon Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
0.00 0.00 0.00 0.00 0.00

Anlon Healthcare Quarterly Data
Mar22 Mar23 Mar24 Jun24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:AHCL
17GF Score
Anlon Healthcare Ltd NSE:AHCL
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anlon Healthcare Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0 Mil mean?
Anlon Healthcare (NSE:AHCL) has a Notes Receivable of ₹0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Anlon Healthcare and its competitors.
Is Anlon Healthcare's Notes Receivable too high?
Anlon Healthcare's current Notes Receivable is ₹0 Mil. Overall, Anlon Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's Notes Receivable compare to ZTS and UTHR?
Anlon Healthcare's Notes Receivable of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Anlon Healthcare and its competitors. Anlon Healthcare's current Notes Receivable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current Notes Receivable of ₹0 Mil. The current Notes Receivable is ₹0 Mil. Anlon Healthcare's overall GF Score™ is 17/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anlon Healthcare Business Description

Other Exchanges 544497:India
Address Kalawad Road, 101/102, Silvercoin Complex, Opposite Crystal Mall, Rajkot, GJ, IND, 360 005
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
17GF Score

Get the complete analysis for NSE:AHCL

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.90
Price